Pennsylvania-based FloBio (NSF-2035983) helps minimize risk of severe bleeding. Its diagnostic helps doctors to quickly assess blood clotting status and identify whether a patient is taking direct oral anticoagulants (DOACs). FloBio recently received breakthrough device designation from the Food and Drug Administration. Article via Medical Device Network